Physician
Holston Medical Group PC
Holston Medical Group PC was paid $36.90M by Medicaid between Jan 2018 and Dec 2024, across 236 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
33Billing provider infoHOLSTON MEDICAL GROUP PC
KINGSPORT, TN 37660
KINGSPORT, TN 37660
33aNPI1831110667assigned 07/21/2006
33bProvider typePediatrics Physician
28Total paid$36.90M
24GClaims1,169,685
24DCodes billed236
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Tennessee
Rank by total paid#1 of 333
Median peer was paid$139K
This provider vs. median265×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 122,855 | $3.28M | |
| 2019 | 158,082 | $4.52M | |
| 2020 | 115,442 | $4.07M | |
| 2021 | 147,013 | $5.36M | |
| 2022 | 174,100 | $6.71M | |
| 2023 | 225,104 | $6.73M | |
| 2024incomplete | 227,089 | $6.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 247,670 | 211,025 | $11.59M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 261,446 | 226,192 | $10.72M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.8% | 49,810 | 38,464 | $1.75M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.4% | 27,451 | 21,561 | $1.63M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.4% | 23,508 | 20,550 | $1.63M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.2% | 10,469 | 9,813 | $829K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.0% | 10,954 | 9,784 | $748K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.9% | 22,638 | 7,099 | $708K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.5% | 11,439 | 10,111 | $543K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 11,729 | 11,077 | $513K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 12,184 | 11,585 | $435K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.0% | 5,119 | 4,349 | $379K |
224 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.0% | 4,817 | $376K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 2,480 | $364K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 49,839 | $325K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 1,841 | $244K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 9,557 | $230K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 6,636 | $218K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,641 | $201K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,607 | $185K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,586 | $146K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,619 | $128K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,727 | $113K |
| 97161 | <1% | 2,111 | $107K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 5,729 | $102K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 11,928 | $102K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 848 | $100K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 334 | $98K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,765 | $93K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 946 | $86K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,892 | $82K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 495 | $78K |
| 20610 | <1% | 2,729 | $77K | |
| 96161 | <1% | 5,550 | $73K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,082 | $71K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,573 | $71K |
| 99336 | <1% | 2,668 | $64K | |
| 96160 | <1% | 4,530 | $63K | |
| 95886 | <1% | 743 | $61K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,092 | $59K |
| 90686 | <1% | 12,535 | $59K | |
| 99460 | <1% | 1,157 | $55K | |
| 76536 | <1% | 1,198 | $52K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 27,635 | $50K |
| 96127 | <1% | 10,187 | $45K | |
| 99177 | <1% | 6,092 | $43K | |
| 95811 | <1% | 146 | $43K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,003 | $40K |
| 92551 | <1% | 5,257 | $39K | |
| 76830 | Ultrasound, transvaginal | <1% | 428 | $38K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,314 | $31K |
| 90670 | <1% | 10,492 | $31K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 180 | $30K |
| 95911 | <1% | 261 | $29K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,892 | $28K |
| 92567 | <1% | 2,739 | $26K | |
| 99199 | Unlisted special service, procedure or report | <1% | 7,473 | $25K |
| 99223 | Prolong inpt eval add15 m | <1% | 521 | $24K |
| 72141 | <1% | 183 | $24K | |
| 81001 | <1% | 9,634 | $22K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,249 | $22K |
| 95117 | <1% | 2,653 | $22K | |
| 64721 | <1% | 88 | $21K | |
| 99442 | <1% | 673 | $19K | |
| 43235 | <1% | 265 | $19K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 120 | $18K |
| 11721 | <1% | 3,094 | $17K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 691 | $17K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 191 | $17K |
| 90723 | <1% | 9,099 | $16K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 292 | $16K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 247 | $16K |
| 73130 | <1% | 720 | $15K | |
| 54150 | <1% | 94 | $15K | |
| 99174 | <1% | 1,459 | $14K | |
| 90680 | <1% | 7,251 | $14K | |
| 99173 | <1% | 2,610 | $14K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 171 | $14K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 229 | $13K |
| 90677 | <1% | 2,468 | $13K | |
| 90647 | <1% | 8,655 | $13K | |
| 95251 | <1% | 1,041 | $13K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 255 | $12K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 312 | $12K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,687 | $11K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 993 | $11K |
| 73630 | <1% | 649 | $11K | |
| 97162 | <1% | 261 | $11K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 846 | $11K |
| 99349 | <1% | 283 | $11K | |
| 99335 | <1% | 637 | $10K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 520 | $10K |
| 87807 | <1% | 880 | $10K | |
| 90651 | <1% | 992 | $10K | |
| 73221 | <1% | 61 | $9K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,373 | $9K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 52 | $9K |
| 71250 | <1% | 145 | $8K | |
| 77080 | <1% | 696 | $8K | |
| 73110 | <1% | 327 | $8K | |
| 94010 | <1% | 400 | $8K | |
| 90633 | <1% | 3,461 | $7K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 709 | $7K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 308 | $7K |
| 99462 | <1% | 270 | $7K | |
| 99490 | Ccm add 20min | <1% | 3,482 | $6K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 48 | $6K |
| 73565 | <1% | 494 | $6K | |
| 76642 | <1% | 145 | $6K | |
| 76801 | <1% | 77 | $6K | |
| 73560 | <1% | 486 | $6K | |
| 81003 | <1% | 4,007 | $6K | |
| 86738 | <1% | 767 | $6K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 29 | $5K |
| 43249 | <1% | 40 | $5K | |
| 81025 | <1% | 977 | $5K | |
| 99459 | <1% | 378 | $5K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 414 | $4K |
| 43450 | <1% | 170 | $4K | |
| 95909 | <1% | 53 | $4K | |
| 94726 | <1% | 199 | $4K | |
| 90734 | <1% | 776 | $4K | |
| 0012A | <1% | 141 | $4K | |
| 92553 | <1% | 248 | $4K | |
| 90656 | <1% | 734 | $4K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 43 | $3K |
| 94729 | <1% | 160 | $3K | |
| 91200 | <1% | 181 | $3K | |
| 90461 | <1% | 3,609 | $3K | |
| 99243 | <1% | 37 | $3K | |
| 95800 | <1% | 29 | $3K | |
| 76770 | <1% | 52 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 94 | $3K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 531 | $3K |
| 90671 | <1% | 1,593 | $3K | |
| 99441 | <1% | 199 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 527 | $3K |
| 99439 | <1% | 866 | $2K | |
| 0011A | <1% | 167 | $2K | |
| 90715 | <1% | 215 | $2K | |
| 73030 | <1% | 109 | $2K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 17 | $2K |
| 90716 | <1% | 659 | $2K | |
| 99443 | <1% | 90 | $2K | |
| 93244 | <1% | 201 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $2K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 2,182 | $2K |
| 74018 | <1% | 77 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 15 | $1K |
| 36416 | <1% | 794 | $1K | |
| 11750 | <1% | 16 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 130 | $1K |
| 99050 | <1% | 87 | $1K | |
| 97597 | <1% | 72 | $1K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 14 | $1K |
| 99306 | Prolong nursin fac eval 15m | <1% | 137 | $1K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 14 | $1K |
| 93242 | <1% | 201 | $1K | |
| 90707 | <1% | 654 | $1K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 38 | $986.49 |
| 90662 | <1% | 337 | $970.36 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 54 | $926.89 |
| 3078F | <1% | 19,712 | $903.92 | |
| 77066 | Tomosynthesis, mammo | <1% | 18 | $895.90 |
| 72110 | <1% | 33 | $872.47 | |
| 92557 | <1% | 29 | $872.26 | |
| 73140 | <1% | 36 | $824.69 | |
| 90710 | <1% | 163 | $823.37 | |
| 3074F | <1% | 23,029 | $803.92 | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,402 | $774.70 |
| 93224 | <1% | 13 | $749.22 | |
| 96380 | <1% | 42 | $720.65 | |
| 90688 | <1% | 531 | $693.73 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 15 | $673.71 |
| 93922 | <1% | 13 | $657.06 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 483 | $653.51 |
| 0071A | <1% | 18 | $641.00 | |
| 99406 | <1% | 330 | $629.63 | |
| 90696 | <1% | 218 | $585.39 | |
| 0072A | <1% | 14 | $560.00 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 18 | $557.67 |
| 90674 | <1% | 1,386 | $502.31 | |
| 3008F | <1% | 25,626 | $502.01 | |
| 90685 | <1% | 537 | $482.63 | |
| 69210 | <1% | 19 | $459.48 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 89 | $304.53 |
| 3079F | <1% | 6,439 | $300.00 | |
| 87400 | <1% | 70 | $297.99 | |
| 94664 | <1% | 54 | $296.29 | |
| 93000 | <1% | 24 | $288.05 | |
| 99305 | <1% | 44 | $273.94 | |
| 73562 | <1% | 16 | $270.05 | |
| 0500F | <1% | 22 | $260.00 | |
| 85027 | <1% | 78 | $257.02 | |
| 94060 | <1% | 16 | $255.29 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 205 | $234.25 |
| 0502F | <1% | 13,424 | $225.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 645 | $222.90 |
| 11720 | <1% | 44 | $211.47 | |
| 11719 | <1% | 77 | $176.11 | |
| 3075F | <1% | 2,307 | $173.58 | |
| 51798 | <1% | 60 | $156.27 | |
| 3077F | <1% | 1,180 | $125.00 | |
| 99310 | Prolong nursin fac eval 15m | <1% | 14 | $102.90 |
| 0503F | <1% | 46 | $95.04 | |
| 90672 | <1% | 37 | $77.20 | |
| 86580 | <1% | 41 | $52.65 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 28 | $52.43 |
| 99070 | <1% | 13 | $45.00 | |
| 3046F | <1% | 46 | $35.00 | |
| 3080F | <1% | 383 | $25.00 | |
| 90700 | <1% | 40 | $22.68 | |
| 3044F | <1% | 41 | $20.00 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 162 | $16.45 |
| 0501F | <1% | 27 | $10.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 117 | $7.00 |
| 91307 | <1% | 44 | $0.03 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 8,044 | $0.02 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 90 | $0.00 |
| 99024 | 0% | 1,596 | $0.00 | |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 253 | $0.00 |
| 91301 | 0% | 280 | $0.00 | |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 0% | 82 | $0.00 |
| 3014F | 0% | 47 | $0.00 | |
| G1007 | Clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria program | 0% | 85 | $0.00 |
| 94760 | 0% | 32 | $0.00 | |
| 3351F | 0% | 53 | $0.00 | |
| 1036F | 0% | 274 | $0.00 | |
| 3052F | 0% | 13 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 51 | $0.00 |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 31 | $0.00 |
| G9662 | Previously diagnosed or have a diagnosis of clinical ascvd, including ascvd procedure | 0% | 35 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 7,223 | $0.00 |
| 3288F | 0% | 434 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 44 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARMSTRONG, SHAWNA (CFO)